Sinofn Health
Sinofn Health
Rome, historically the heart of Europe, is undergoing a modern industrial transformation. The Lazio region has emerged as a critical hub for pharmaceutical and nutraceutical innovation. As consumer demand for "Functional Foods" and "Personalized Nutrition" surges in the Italian market, local brands are increasingly seeking OEM/ODM partners who can bridge the gap between scientific complexity and high-speed market entry.
Strategic Insight: The Rome market demands more than just manufacturing; it requires compliance with EFSA (European Food Safety Authority) regulations and a deep understanding of the Mediterranean wellness ethos.
Science-Driven OEM for Global Supplement Brands. SINOFN Health Co., Ltd. is the dedicated supplement OEM manufacturing division of SINOFN Group – a national high-tech enterprise founded in 2012 and backed by the Chinese Academy of Sciences (CAS).
Established in 2025, we operate from Shanghai as the trading hub for global partners seeking premium, science-driven contract manufacturing services. Our entry into the Rome market signifies our commitment to bringing elite R&D capabilities to the Italian healthcare ecosystem.
Building excellent product quality with a professional elite team led by PhDs and Associate Researchers.
Medical Innovation Director
Ph.D Peking University Medical School. 15+ years in metabolic disorder formulations.
R&D Lead
Associate Researcher, CAS Postdoc. Specialist in bioactive compound delivery systems.
Formulation Director
Senior Scientist (Netherlands). EU regulatory specialist in nutraceutical delivery tech.
10+ dedicated lines (softgels, gummies, powders). ISO 22000, HACCP, FSSC 22000 certified. Annual capacity: 500M+ units.
HPLC/GC-MS contaminant screening and stability validation ensuring compliance for Rome market entry.
Raw material storage tracking and BRCGS-certified warehousing for full supply chain transparency.
The nutraceutical industry is shifting from generic supplementation to "targeted bioavailability." Our roadmap for the Rome market includes:
By leveraging China's massive industrial scale and Shanghai’s logistics hub, SINOFN provides Rome-based brands with a 30% reduction in time-to-market compared to traditional EU manufacturing, without compromising on medical-grade quality.
Our legacy in Phenylketonuria (PKU) foods makes us the world leader in sensitive metabolic nutrition.
During her clinical work, Mrs. Liu witnessed lifelong struggles of PKU children – where specialized diets were financially out of reach. Driven to bridge this gap, she founded SINOFN in 2012 to develop affordable, science-backed PKU foods.
"We measure success not just in revenue, but in lives improved through accessible science."
Ensuring absolute compliance with ISO, HACCP, and HALAL standards.
Sinofn prioritizes intellectual property, holding 36 patents (11 invention, 12 utility model, 11 software copyrights, 2 design) and 71 multi-category trademarks. We are certified with ISO9001, ISO22000, HACCP, and HALAL, demonstrating our commitment to quality and safety.
Addressing key concerns for Rome-based businesses and international brands.
Our main manufacturing base is in China, with R&D in Tianjin and a global trading hub in Shanghai. We provide seamless shipping and logistics support for the Rome market and wider Italy regions.
Yes, we offer pilot-scale prototyping for tablets, capsules, and liquids, allowing brands to test small batches before full-scale commercialization.
We offer tailored scopes of work, supporting both emerging wellness brands in Rome and established global enterprises looking for resilient supply chains.
Our formulation director, Hans van Dijk, is a specialist in EU regulatory requirements. We ensure all ingredients and labels meet EFSA and Italian Ministry of Health standards.
